Human Papillomaviruse Vaccine Not Far Off

Main Category: Sexual Health / STDs
Article Date: 23 Jan 2005 - 7:00 PDT

email to a friend   printer friendly   opinions  

As more and more promising results of clinical trials on vaccination against human papillomaviruses are published, the more likely it becomes that an HPV vaccine will be the first licensed immunization against a sexually transmitted disease.

Because UAB researchers are aware of the enormous implications such a vaccine would have, they are attacking the issue in full force.

"If we could vaccinate women early, we could hopefully prevent the development of a very large proportion of cervical cancer 20, 30 or 40 years down the road," said Warner Huh, M.D., UAB gynecologic oncologist.

UAB researchers are participating in four clinical trials addressing HPV vaccine efficacy and reliable testing methods, as well as several international study projects.

University of Alabama at Birmingham
701 20th St. S., AB 1320
Birmingham, AL 35294-0113, USA
Phone 205-934-3884
Fax 205-975-9458
http://www.uab.edu/news

• Additional
• References
• Citations